標(biāo)題: Titlebook: Aging and Heart Failure; Mechanisms and Manag Bodh I. Jugdutt Book 2014 Springer Science+Business Media New York 2014 aging.heart failure.m [打印本頁] 作者: Hoover 時間: 2025-3-21 16:48
書目名稱Aging and Heart Failure影響因子(影響力)
書目名稱Aging and Heart Failure影響因子(影響力)學(xué)科排名
書目名稱Aging and Heart Failure網(wǎng)絡(luò)公開度
書目名稱Aging and Heart Failure網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Aging and Heart Failure被引頻次
書目名稱Aging and Heart Failure被引頻次學(xué)科排名
書目名稱Aging and Heart Failure年度引用
書目名稱Aging and Heart Failure年度引用學(xué)科排名
書目名稱Aging and Heart Failure讀者反饋
書目名稱Aging and Heart Failure讀者反饋學(xué)科排名
作者: Herbivorous 時間: 2025-3-21 23:52 作者: PLE 時間: 2025-3-22 01:30
Hypertension and Prevention of Diastolic Heart Failure in the Aging Population,eart failure (HF). The prevalence of a normal left ventricular (LV) ejection fraction (EF) associated with HF or diastolic HF (DHF) increases with age, is higher in older women than in older men, and is present in approximately half of older HF patients. Hypertension is more common in patients with 作者: 泥瓦匠 時間: 2025-3-22 08:04 作者: d-limonene 時間: 2025-3-22 11:43 作者: grenade 時間: 2025-3-22 15:12
Optimizing Therapy of Heart Failure in the Aging Population with Monitoring in Clinics,cts <1 % of adults under 50 years of age, but in patients over 80, the prevalence exceeds 10 %. Optimizing heart failure therapy in clinics under the guidance of multidisciplinary management teams has been shown to reduce readmission rates and mortality. Several contemporary randomized trials have s作者: 我的巨大 時間: 2025-3-22 17:32
Cardiac Alterations in Aging, Hypertension, and Diastolic Heart Failure,endent risk factor of CVD, in part due to progressive exposure to a variety of insults including smoking, obesity, hypertension (HTN), and chronic diseases. Population studies on aging demonstrate linear increases in systolic blood pressure throughout each decade of life. HTN is the most commonly id作者: 墻壁 時間: 2025-3-22 21:55 作者: 看法等 時間: 2025-3-23 02:23 作者: 一夫一妻制 時間: 2025-3-23 07:14
Biomarkers and Optimal Management of Heart Failure in the Aging Population,predispose the elderly to developing HF and small insults may rapidly precipitate decompensation of symptoms. There are special challenges in diagnosing and managing elderly patients with HF, challenges that biomarkers can help mitigate. Natriuretic peptides such as B-type natriuretic peptide and N-作者: glowing 時間: 2025-3-23 10:24 作者: 馬賽克 時間: 2025-3-23 16:15
The RAAS in Heart Failure: An Update on Clinical Trials and Opportunities for Therapy,condition, its medical management remains a challenge, with a significant 5-year mortality. At the present time, treatment of heart failure has centered on the idea that its clinical manifestations are associated with a derangement of the renin-angiotensin-aldosterone system (RAAS) leading eventuall作者: Locale 時間: 2025-3-23 22:00 作者: ACTIN 時間: 2025-3-23 22:25
Reperfusion and Vasodilator Therapy in Elderly Patients with STEMI and Heart Failure: Improving Out (CV) changes with aging predispose the elderly to HF. Comorbidities such as coronary artery disease with ST-segment-elevation myocardial infarction (STEMI) and hypertension (HTN) are more prevalent in the elderly and contribute to the development of HF. Morbidity, hospitalizations, and costs associ作者: Congeal 時間: 2025-3-24 06:00 作者: 綠州 時間: 2025-3-24 06:39 作者: APRON 時間: 2025-3-24 11:40 作者: 偶像 時間: 2025-3-24 17:09
Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Theradiseases, including myocardial infarction (MI), hypertension (HTN), and HF, are all more prevalent in the elderly. While the renin–angiotensin system (RAS) has critical functions in CV physiology, an upregulated RAS plays a critical role in CV pathophysiology, including post-MI dilative remodeling a作者: VOK 時間: 2025-3-24 20:13 作者: 高調(diào) 時間: 2025-3-25 03:05 作者: oxidize 時間: 2025-3-25 03:32
https://doi.org/10.1007/978-981-97-3187-9ng and managing elderly patients with HF, challenges that biomarkers can help mitigate. Natriuretic peptides such as B-type natriuretic peptide and N-terminal proBNP are established biomarkers that have been proven to accurately diagnose and prognosticate HF. There are additional promising novel biomarkers that may be of use.作者: RODE 時間: 2025-3-25 09:44 作者: adduction 時間: 2025-3-25 12:00
Book 2014cades and addresses future directions in management and drug discovery. It presents clinical issues and molecular mechanisms related to heart failure, including the changing demographics in the aging population with heart failure; hypertension and prevention of diastolic heart failure in the aging p作者: Restenosis 時間: 2025-3-25 19:34
https://doi.org/10.1007/978-3-031-58480-0nterest for the elderly although they have not been extensively studied in this group of patients..This chapter will review the epidemiology, pathophysiology and management options for AF and discuss the role of new advances in management of AF in the elderly.作者: commodity 時間: 2025-3-25 21:59
https://doi.org/10.1007/978-981-97-7812-6herapy in older patients and discusses strategies for minimizing the risk of adverse drug events. In addition, the intersection between heart failure medications and common geriatric syndromes, including polypharmacy, falls and syncope, and fatigue and low energy, is briefly reviewed.作者: 打火石 時間: 2025-3-26 01:05
Do Humans Think Causally, and How?,aining in the elderly together with some of the evidence supporting health benefits that are likely to follow in patients with common non-communicable diseases associated with ageing, such as coronary atherosclerosis, hypertension, diabetes, obesity, and osteoporosis.作者: anesthesia 時間: 2025-3-26 07:44
Concluding (and Reopening) Remarksas a more complex system involving a variety of cell types which influence the functions of the cardiovascular system in health and disease. The latter effects, particularly those involving the actions of nitric oxide and endothelial cell function, may open new options for therapy in the future.作者: TOXIC 時間: 2025-3-26 08:56
Atrial Fibrillation and Heart Failure in the Aging Population,nterest for the elderly although they have not been extensively studied in this group of patients..This chapter will review the epidemiology, pathophysiology and management options for AF and discuss the role of new advances in management of AF in the elderly.作者: 我們的面粉 時間: 2025-3-26 12:54 作者: Kindle 時間: 2025-3-26 18:42 作者: 采納 時間: 2025-3-26 22:46 作者: 陳腐思想 時間: 2025-3-27 03:53 作者: Humble 時間: 2025-3-27 07:22
https://doi.org/10.1007/978-3-031-58480-0for more than 50 % of HF cases in the elderly with outcomes equally dismal as those with systolic heart failure. Only recently has the interaction of CVD and physiologic effects of aging attracted attention; therefore, many aspects are yet to be elucidated. ..作者: Hyperalgesia 時間: 2025-3-27 12:55 作者: Dri727 時間: 2025-3-27 14:33 作者: Perineum 時間: 2025-3-27 21:38
https://doi.org/10.1007/978-3-031-63516-8mary PHTN, and similar findings are emerging in other types of PHTN, especially PHTN associated with left heart failure. Much more studies are needed to elucidate the clinical significance of right ventricular remodeling and failure in relation to aging and to define whether this could be a therapeutic target for improving outcomes of the disease.作者: 沙草紙 時間: 2025-3-28 00:28 作者: geriatrician 時間: 2025-3-28 03:41
Cardiac Alterations in Aging, Hypertension, and Diastolic Heart Failure,for more than 50 % of HF cases in the elderly with outcomes equally dismal as those with systolic heart failure. Only recently has the interaction of CVD and physiologic effects of aging attracted attention; therefore, many aspects are yet to be elucidated. ..作者: Compatriot 時間: 2025-3-28 09:42
Age-Related Changes in Vascular Biology and Implications for Heart Failure Therapy in the Aging Pop function, and putative molecular mechanism of aging in the cardiovascular system and discuss briefly implications of these observations for future efforts to prevent and to treat heart failure in elderly populations.作者: Noctambulant 時間: 2025-3-28 11:41
Role of Resistin in Heart Failure in the Elderly,In addition, resistin is strongly associated with risk for incident heart failure in Cox proportional hazard models controlling for clinical variables, inflammatory biomarkers, and measures of adiposity.作者: JECT 時間: 2025-3-28 15:37 作者: 泰然自若 時間: 2025-3-28 19:07 作者: Statins 時間: 2025-3-29 01:05
D-Critical D/K Equivalence Conjectures,in most developing countries. This growing burden of HF threatens to tax healthcare systems worldwide. Aging is a natural biological process that is progressive and is associated with cardiovascular (CV) changes that impact disease expression and response to therapy. Aging results in increased risk 作者: 臆斷 時間: 2025-3-29 04:12
D-Critical D/K Equivalence Conjectures,eart failure (HF). The prevalence of a normal left ventricular (LV) ejection fraction (EF) associated with HF or diastolic HF (DHF) increases with age, is higher in older women than in older men, and is present in approximately half of older HF patients. Hypertension is more common in patients with 作者: Accord 時間: 2025-3-29 09:10 作者: 實施生效 時間: 2025-3-29 13:45 作者: acolyte 時間: 2025-3-29 16:58 作者: Obituary 時間: 2025-3-29 23:37 作者: aspect 時間: 2025-3-30 02:49
https://doi.org/10.1007/978-981-97-7812-6ribution, metabolism, and elimination of virtually all drugs. In addition, older patients with heart failure almost invariably have multiple coexisting medical conditions for which they are receiving medications. Taken together, these factors greatly increase the risk for adverse drug events and dru作者: 喚起 時間: 2025-3-30 06:56
Kaijun Wang,Ying Fang,Tianjian Luon elderly populations due in part to increased prevalence of risk factors for heart failure, aging itself can alter the structure and function of the cardiovascular system, including the arterial tree as well as the myocardium, and contribute to heart failure independent of comorbidities or other ex作者: 結(jié)構(gòu) 時間: 2025-3-30 09:39
https://doi.org/10.1007/978-981-97-3187-9predispose the elderly to developing HF and small insults may rapidly precipitate decompensation of symptoms. There are special challenges in diagnosing and managing elderly patients with HF, challenges that biomarkers can help mitigate. Natriuretic peptides such as B-type natriuretic peptide and N-作者: lactic 時間: 2025-3-30 12:28 作者: 礦石 時間: 2025-3-30 19:11 作者: 細節(jié) 時間: 2025-3-30 23:40
Concluding (and Reopening) Remarksth heart failure and reduced ejection fraction (EF) and are more often females. Patients with heart failure with preserved ejection fraction (HFPEF) have an increased mortality and morbidity rate and have been found to be similar compared with patients with heart failure and reduced EF. One of the u作者: hazard 時間: 2025-3-31 01:13
https://doi.org/10.1007/978-3-031-65119-9 (CV) changes with aging predispose the elderly to HF. Comorbidities such as coronary artery disease with ST-segment-elevation myocardial infarction (STEMI) and hypertension (HTN) are more prevalent in the elderly and contribute to the development of HF. Morbidity, hospitalizations, and costs associ作者: Armory 時間: 2025-3-31 05:44
https://doi.org/10.1007/978-3-031-64521-1adult patients with heart failure, the use of erythropoietin within this cohort has been embraced as a potential therapy for improving outcomes including quality of life. Clinical trials of erythropoietin in systolic heart failure have demonstrated several positive effects of the drug on cardiovascu作者: minaret 時間: 2025-3-31 11:44
I. Kuvvetli,S. R. H. Owe,C. Budtz-J?rgensenal studies have demonstrated that circulating resistin is associated with inflammation, coronary atherosclerosis, renal dysfunction, adverse prognosis in patients with atherothrombotic ischemic stroke, and heart failure. In the population-based observational study, increased circulating levels of re作者: 愛社交 時間: 2025-3-31 15:08
https://doi.org/10.1007/978-3-031-63516-8 coronary heart disease. Controlling cardiovascular risk factors for coronary heart disease is the most effective way to reduce the burden of ischemic cardiomyopathy in elderly populations. Appropriate application of proven preventive therapies relies heavily on the accurate estimation of cardiovasc作者: 外表讀作 時間: 2025-3-31 21:19 作者: Fatten 時間: 2025-3-31 22:16
https://doi.org/10.1007/978-3-031-63516-8left heart failure and chronic lung disease and obese patients with metabolic syndrome. Evidence indicates that aging alters the pulmonary vascular tree histology, right ventricular structure, and hemodynamics in the pulmonary circulation. There is not much research exploring mechanisms of how aging作者: BILL 時間: 2025-4-1 03:06
